ADC Therapeutics SA (ADCT) — Cash Flow Reinvestment Rate
Latest as of September 2022:
0.23x
ADC Therapeutics SA (ADCT) has a Cash Flow Reinvestment Rate of 0.23x as of September 2022, reinvesting $508.00K (capex $254.00K plus investments $-254.00K) from operating cash flow of $2.19 Million. See ADC Therapeutics SA (ADCT) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.23x
(Capex + Investments) / Operating CF
Total Reinvested
$508.00K
Capex + Investments
Operating Cash Flow
$2.19 Million
USD
Capital Expenditures
$254.00K
USD
Annual Cash Flow Reinvestment Rate for ADC Therapeutics SA (None–None)
Year-by-year capital reinvestment analysis for ADC Therapeutics SA. See financial flexibility index of ADC Therapeutics SA to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow